Vivos Therapeutics Inc (VVOS)

Feb 20, 2025

Reviewing Vivos Therapeutics (NASDAQ:VVOS) & Biostage (OTCMKTS:BSTG) - Defense World

Feb 20, 2025

Feb 19, 2025

Vivos Therapeutics Inc to Host Earnings Call - ACCESS Newswire

Feb 19, 2025

Feb 18, 2025

Vivos Therapeutics to participate in Fireside Chat with Water Tower Research - Proactive Investors UK

Feb 18, 2025

Feb 18, 2025

Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm - EIN News

Feb 18, 2025

Feb 16, 2025

Investors Give Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares A 30% Hiding - Simply Wall St

Feb 16, 2025

Feb 16, 2025

Vivos Therapeutics Enters Into At The Market Offering Agreement with H.C. Wainwright & Co., LLC**Littleton, Colo. – Vivos Therapeutics, Inc. (NASDAQ: VVOS) announced on February 14, 2025, that the company has entered into an At The Market Offering - Defense World

Feb 16, 2025

Feb 15, 2025

Vivos Therapeutics Enters Market Offering Agreement with Wainwright - TipRanks

Feb 15, 2025

Feb 12, 2025

Vivos Therapeutics announces up to $50M mixed shelf offering - MSN

Feb 12, 2025

Feb 11, 2025

Vivos Therapeutics Inc Files For Mixed Shelf Of Up To $50 MillionSEC Filing -February 11, 2025 at 05:44 pm EST - Marketscreener.com

Feb 11, 2025

Jan 29, 2025

Trapped in CPAP Dependency? Vivos Liberates OSA Patients with Non-Invasive Solution - PR Web

Jan 29, 2025

Jan 25, 2025

Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders - MSN

Jan 25, 2025

Jan 22, 2025

Vivos Therapeutics (VVOS) Stock Price, News & Analysis - MarketBeat

Jan 22, 2025

Jan 13, 2025

VVOS Stock Price and Chart — NASDAQ:VVOS — TradingView«Кавказ Пост» - «Кавказ Пост» - новости Северного Кавказа и Закавказья

Jan 13, 2025

Jan 09, 2025

Best Momentum Stocks to Buy for January 8th - MSN

Jan 09, 2025

Jan 08, 2025

Recognizing Sleep as the Sixth Vital Sign: How Vivos Is Redefining Health Care - PR Web

Jan 08, 2025

Dec 31, 2024

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Up 28.9% in December - Defense World

Dec 31, 2024

Dec 27, 2024

After Leaping 35% Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 27, 2024

Dec 23, 2024

Vivos Therapeutics announces $3.5 million stock offering - Investing.com

Dec 23, 2024

Dec 23, 2024

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times

Dec 23, 2024

Dec 23, 2024

Vivos Therapeutics Secures $3.5M Financing Through Strategic Share Offering and Warrants - StockTitan

Dec 23, 2024

Dec 23, 2024

Vivos Therapeutics announces funding boost - Proactive Investors USA

Dec 23, 2024

Dec 21, 2024

Vivos Therapeutics (NASDAQ:VVOS) Stock Price Up 6.9% – What’s Next? - Defense World

Dec 21, 2024

Dec 18, 2024

All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy - Yahoo Finance

Dec 18, 2024

Dec 16, 2024

FDA-Cleared Therapy for Pediatric Sleep Apnea From Vivos Offers Parents and Providers New Hope - PR Web

Dec 16, 2024

Dec 13, 2024

Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga

Dec 13, 2024

Dec 11, 2024

Water Tower Research Publishes Initiation of Coverage Report on Vivos Therapeutics, Inc., "New Strategic Model & Key Regulatory Milestones Provide Revenue Tailwind" - Big News Network

Dec 11, 2024

Dec 10, 2024

Vivos, Cellev8 Launch Strategic Sleep Apnea Venture: FDA-Cleared Devices Meet Breakthrough Nutraceuticals - StockTitan

Dec 10, 2024

Dec 10, 2024

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress - ACCESS Newswire

Dec 10, 2024

Dec 04, 2024

Vivos and SleepImage © Revolutionize Sleep Apnea Diagnostics with Affordable Home Sleep Testing Solutions - PR Web

Dec 04, 2024

Nov 28, 2024

Vivos Therapeutics shareholders elect directors, approve equity plan By Investing.com - Investing.com South Africa

Nov 28, 2024

Nov 28, 2024

Vivos Therapeutics shareholders elect directors, approve equity plan - Investing.com India

Nov 28, 2024

Nov 26, 2024

Sleep Apnea: Vivos' FDA-Cleared Technology Offers Revolutionary, Non-Invasive Hope for America's Stealth Epidemic - PR Web

Nov 26, 2024

Nov 22, 2024

Medicare to reimburse for Vivos CARE sleep apnea devices - MSN

Nov 22, 2024

Nov 22, 2024

Ascendiant Capital Markets Reiterates Buy Rating for Vivos Therapeutics (NASDAQ:VVOS) - Defense World

Nov 22, 2024

Nov 17, 2024

Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

Earnings call: Vivos Therapeutics sees revenue growth in Q3 2024 - Investing.com

Nov 15, 2024

Nov 15, 2024

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Vivos Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Vivos Therapeutics Inc (VVOS) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Q3 Brings Revenue Gains and Key Regulatory Milestones for Vivos - Sleep Review

Nov 15, 2024

Nov 14, 2024

Vivos Therapeutics Reports Revenue Growth and Strategic Milestones - TipRanks

Nov 14, 2024

Nov 14, 2024

Vivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3 - Proactive Investors USA

Nov 14, 2024

Nov 14, 2024

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update - The Manila Times

Nov 14, 2024

Nov 14, 2024

Vivos Therapeutics Q3 Revenue Jumps 17% as FDA Approves Pediatric OSA Treatment | VVOS Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call - The Manila Times

Nov 13, 2024

Nov 12, 2024

Even With A 27% Surge, Cautious Investors Are Not Rewarding Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Performance Completely - Simply Wall St

Nov 12, 2024